Age, Biography and Wiki
Aaron Ciechanover was born on 1 October, 1947 in Haifa, British Mandate of Palestine (now Israel), is an Israeli biologist and Nobel Laureate. Discover Aaron Ciechanover's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 76 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
76 years old |
| Zodiac Sign |
Libra |
| Born |
1 October 1947 |
| Birthday |
1 October |
| Birthplace |
Haifa, British Mandate of Palestine (now Israel) |
| Nationality |
Israel
|
We recommend you to check the complete list of Famous People born on 1 October.
He is a member of famous with the age 76 years old group.
Aaron Ciechanover Height, Weight & Measurements
At 76 years old, Aaron Ciechanover height not available right now. We will update Aaron Ciechanover's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Who Is Aaron Ciechanover's Wife?
His wife is Menucha Ciechanover
| Family |
| Parents |
Not Available |
| Wife |
Menucha Ciechanover |
| Sibling |
Not Available |
| Children |
Not Available |
Aaron Ciechanover Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Aaron Ciechanover worth at the age of 76 years old? Aaron Ciechanover’s income source is mostly from being a successful . He is from Israel. We have estimated Aaron Ciechanover's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Aaron Ciechanover Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
His mother and father supported the Zionist movement and immigrated to Israel from Poland in the 1920s.
Aaron Ciechanover (אהרן צ'חנובר; born October 1, 1947) is an Israeli biologist who won the Nobel Prize in Chemistry for characterizing the method that cells use to degrade and recycle proteins using ubiquitin.
Ciechanover was born in Haifa, British Mandate of Palestine on 1 October 1947 into a Jewish family.
He is the son of Bluma (Lubashevsky), a teacher of English, and Yitzhak Ciechanover, an office worker.
He earned a master's degree in science in 1971 and graduated from Hadassah Medical School in Jerusalem in 1974.
He received his doctorate in biochemistry in 1981 from the Technion – Israel Institute of Technology in Haifa before conducting postdoctoral research in the laboratory of Harvey Lodish at the Whitehead Institute at MIT from 1981 to 1984.
Ciechanover is currently a Technion Distinguished Research Professor in the Ruth and Bruce Rappaport Faculty of Medicine and Research Institute at the Technion.
He is a member of the Israel Academy of Sciences and Humanities, the Pontifical Academy of Sciences, the National Academy of Sciences of Ukraine, the Russian Academy of Sciences and is a foreign associate of the United States National Academy of Sciences.
Ciechanover is one of Israel's first Nobel Laureates in science, earning his Nobel Prize in 2004 for his work in ubiquitination.
He is honored for playing a central role in the history of Israel and in the history of the Technion – Israel Institute of Technology.
Ciechanover has served on the scientific advisory boards of the following companies: Rosetta Genomics (Chairman), BioLineRx, Ltd, StemRad, Ltd, Allosterix Ltd, Proteologics, Inc, MultiGene Vascular Systems, Ltd, Protalix BioTherapeutics, BioTheryX, Inc., and Haplogen, GmbH.
Ciechanover is a member of the advisory board of Patient Innovation, a nonprofit, international, multilingual, free venue for patients and caregivers of any disease to share their innovations.
In 2008, he was a visiting Distinguished Chair Professor at NCKU, Taiwan.
As part of Shenzhen's 13th Five-Year Plan funding research in emerging technologies and opening "Nobel laureate research labs", in 2018 he opened the Ciechanover Institute of Precision and Regenerative Medicine at the Chinese University of Hong Kong, Shenzhen campus.
